{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:58:10Z","timestamp":1789559890735,"version":"build-2803163510"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2020.581668","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T08:33:55Z","timestamp":1605602035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of Potential Key Agents for Targeting RNA-Dependent RNA Polymerase of SARS-CoV-2 by Integrated Analysis and Virtual Drug Screening"],"prefix":"10.3389","volume":"11","author":[{"given":"Shuang","family":"Ao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1021\/acs.molpharmaceut.6b00248","article-title":"Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data.","volume":"13","author":"Aliper","year":"2016","journal-title":"Mol. Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-019-1717-y","article-title":"A new twenty-first century science for effective epidemic response.","volume":"575","author":"Bedford","year":"2019","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic acids res."},{"key":"B4","year":"2015","journal-title":"Dassault Syst\u00e8mes: Dassault Syst\u00e8mes BIOVIA 2016 ed."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb0659","article-title":"Can an anti-HIV combination or other existing drugs outwit the new coronavirus.","volume":"370","author":"Cohen","year":"2020","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","author":"Dallakyan","year":"2015","journal-title":"Chemical Biology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug repurposing for antimicrobial discovery.","volume":"4","author":"Farha","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.","volume":"295","author":"Gordon","year":"","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.","volume":"295","author":"Gordon","year":"","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.bmcl.2009.02.009","article-title":"Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1: 2).","volume":"19","author":"Heidebrecht","year":"2009","journal-title":"Bioorg. med. Chem. Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"B12","author":"Klambauer","year":"2019","journal-title":"Machine Learning in Drug Discovery."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1016\/j.bmc.2016.05.013","article-title":"Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors.","volume":"24","author":"Kumar","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1016\/j.bmcl.2009.07.009","article-title":"Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase\/helicase by dihydroxychromone derivatives.","volume":"19","author":"Lee","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV).","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel non-peptide inhibitors of severe acute respiratory syndrome coronavirus main protease.","volume":"49","author":"Lu","year":"2006","journal-title":"J. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery.","volume":"38","author":"Macalino","year":"2015","journal-title":"Archiv. Pharm. Res."},{"key":"B18","year":"2015","journal-title":"Ntegrated Development for R. RStudio, Inc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1021\/jm050852f","article-title":"Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.","volume":"49","author":"Tsai","year":"2006","journal-title":"J. Med. Chem."},{"key":"B21","year":"","journal-title":"Coronavirus disease 2019 (COVID-19): situation report, 103."},{"key":"B22","year":"","journal-title":"WHO Director-General\u2019s opening remarks at the Mission briefing on COVID-19."},{"key":"B23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China.","volume":"27","author":"Wu","year":"","journal-title":"Cell Host Microbe"},{"key":"B24","author":"Wu","year":"","journal-title":"A novel coronavirus associated with a respiratory disease in Wuhan of Hubei province. China. NCBI<sup>\u2217<\/sup>."},{"key":"B25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019.","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses \u2014 drug discovery and therapeutic options.","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2020.581668\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T08:33:58Z","timestamp":1605602038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2020.581668\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":26,"alternative-id":["10.3389\/fgene.2020.581668"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2020.581668","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"article-number":"581668"}}